U.S. Overactive Bladder Market

U.S. Overactive Bladder Market

 

RELEASE DATE
13-Nov-2009
REGION
North America
Research Code: N695-01-00-00-00
SKU: HC02132-NA-MR_07682
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02132-NA-MR_07682

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service covers the U.S. overactive bladder market from 2005-2015. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts and market share analysis. The market is segmented by product: Detrol, Detrol LA, Ditropan, Ditropan XL, Enablex, Oxytrol, Sanctura, Sanctura XR, VESIcare, and others. Major market challenges, drivers, and restraints and identified and discussed as well as pipeline by phase.

Table of Contents

U.S. Overactive Bladder Market

  • Introduction

Research Scope and Methodology

  • Scope and Segmentation
  • Research Methodology

Market Overview

  • Market Engineering Measurements
  • Disease Overview
  • Treatment Options
  • Patient Forecasts
  • Industry Challenges
  • Market Drivers
  • Market Restraints

Product Analysis

  • Product Analysis
  • Product Comparisons
  • Recently Approved Products

Pipeline Analysis

  • Phase III
  • Phase II
  • Phase I

Overview

Forecasts and Trends

Market Share Analysis

Decision Support Databases

Related Research
This research service covers the U.S. overactive bladder market from 2005-2015. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts and market share analysis. The market is segmented by product: Detrol, Detrol LA, Ditropan, Ditropan XL, Enablex, Oxytrol, Sanctura, Sanctura XR, VESIcare, and others. Major market challenges, drivers, and restraints and identified and discussed as well as pipeline by phase.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number N695-01-00-00-00
Is Prebook No